Liabilities and Equity of ACCENDRA HEALTH INC/VA/ from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
ACCENDRA HEALTH INC/VA/ quarterly Liabilities and Equity in USD history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • ACCENDRA HEALTH INC/VA/ Liabilities and Equity for the quarter ending 31 Dec 2025 was $2,451,761,000, a 47% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

ACCENDRA HEALTH INC/VA/ Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,451,761,000 -$2,204,395,000 -47% 31 Dec 2025 10-K 20 Feb 2026 2025 FY
Q3 2025 $4,036,226,000 -$1,045,056,000 -21% 30 Sep 2025 10-Q 31 Oct 2025 2025 Q3
Q2 2025 $4,154,545,000 -$1,149,459,000 -22% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $4,856,424,000 -$351,569,000 -6.8% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $4,656,156,000 -$437,166,000 -8.6% 31 Dec 2024 10-K 20 Feb 2026 2025 FY
Q3 2024 $5,081,282,000 -$42,781,000 -0.84% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $5,304,004,000 +$16,004,000 +0.3% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $5,207,993,000 -$102,210,000 -1.9% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $5,093,322,000 -$292,961,000 -5.4% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $5,124,063,000 -$414,519,000 -7.5% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $5,288,000,000 -$267,278,000 -4.8% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $5,310,203,000 -$397,766,000 -7% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $5,386,283,000 +$1,849,732,000 +52% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 $5,538,582,000 +$1,954,463,000 +55% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $5,555,278,000 +$1,963,449,000 +55% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $5,707,969,000 +$2,317,148,000 +68% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $3,536,551,000 +$200,912,000 +6% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $3,584,119,000 +$287,004,000 +8.7% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $3,591,829,000 +$454,043,000 +14% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $3,390,821,000 -$324,049,000 -8.7% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $3,335,639,000 -$307,445,000 -8.4% 31 Dec 2020 10-K 23 Feb 2022 2021 FY
Q3 2020 $3,297,115,000 -$391,304,000 -11% 30 Sep 2020 10-Q 03 Nov 2020 2020 Q3
Q2 2020 $3,137,786,000 -$758,285,000 -19% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $3,714,870,000 -$167,494,000 -4.3% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $3,643,084,000 -$130,704,000 -3.5% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $3,688,419,000 -$343,862,000 -8.5% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $3,896,071,000 -$147,060,000 -3.6% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $3,882,364,000 +$490,810,000 +14% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $3,773,788,000 +$397,495,000 +12% 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q3 2018 $4,032,281,000 +$698,125,000 +21% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 $4,043,131,000 +$1,247,994,000 +45% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 $3,391,554,000 +$691,005,000 +26% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $3,376,293,000 +$658,541,000 +24% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 $3,334,156,000 +$539,524,000 +19% 30 Sep 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 $2,795,137,000 +$39,073,000 +1.4% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 $2,700,549,000 -$96,292,000 -3.4% 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q4 2016 $2,717,752,000 -$56,024,000 -2% 31 Dec 2016 10-K 23 Feb 2018 2017 FY
Q3 2016 $2,794,632,000 +$42,972,000 +1.6% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 $2,756,064,000 -$38,842,000 -1.4% 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 $2,796,841,000 +$97,331,000 +3.6% 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 $2,773,776,000 +$38,370,000 +1.4% 31 Dec 2015 10-K 17 Feb 2017 2016 FY
Q3 2015 $2,751,660,000 -$192,238,000 -6.5% 30 Sep 2015 10-Q 28 Oct 2015 2015 Q3
Q2 2015 $2,794,906,000 +$431,095,000 +18% 30 Jun 2015 10-Q 28 Jul 2015 2015 Q2
Q1 2015 $2,699,510,000 +$330,310,000 +14% 31 Mar 2015 10-Q 28 Apr 2015 2015 Q1
Q4 2014 $2,735,406,000 +$411,364,000 +18% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q3 2014 $2,943,898,000 +$596,232,000 +25% 30 Sep 2014 10-Q 29 Oct 2014 2014 Q3
Q2 2014 $2,363,811,000 -$15,683,000 -0.66% 30 Jun 2014 10-Q 30 Jul 2014 2014 Q2
Q1 2014 $2,369,200,000 +$48,278,000 +2.1% 31 Mar 2014 10-Q 01 May 2014 2014 Q1
Q4 2013 $2,324,042,000 +$109,644,000 +5% 31 Dec 2013 10-K 23 Feb 2015 2014 FY
Q3 2013 $2,347,666,000 +$125,917,000 +5.7% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $2,379,494,000 +$424,070,000 +22% 30 Jun 2013 10-Q 02 Aug 2013 2013 Q2
Q1 2013 $2,320,922,000 +$396,112,000 +21% 31 Mar 2013 10-Q 03 May 2013 2013 Q1
Q4 2012 $2,214,398,000 +$267,583,000 +14% 31 Dec 2012 10-K 25 Feb 2014 2013 FY
Q3 2012 $2,221,749,000 +$272,135,000 +14% 30 Sep 2012 10-Q 02 Nov 2012 2012 Q3
Q2 2012 $1,955,424,000 +$49,554,000 +2.6% 30 Jun 2012 10-Q 27 Jul 2012 2012 Q2
Q1 2012 $1,924,810,000 +$13,630,000 +0.71% 31 Mar 2012 10-Q 27 Apr 2012 2012 Q1
Q4 2011 $1,946,815,000 +$124,776,000 +6.8% 31 Dec 2011 10-K 22 Feb 2013 2012 FY
Q3 2011 $1,949,614,000 +$108,275,000 +5.9% 30 Sep 2011 10-Q 28 Oct 2011 2011 Q3
Q2 2011 $1,905,870,000 +$101,126,000 +5.6% 30 Jun 2011 10-Q 29 Jul 2011 2011 Q2
Q1 2011 $1,911,180,000 31 Mar 2011 10-Q 29 Apr 2011 2011 Q1
Q4 2010 $1,822,039,000 31 Dec 2010 10-K 24 Feb 2012 2011 FY
Q3 2010 $1,841,339,000 30 Sep 2010 10-Q 29 Oct 2010 2010 Q3
Q2 2010 $1,804,744,000 30 Jun 2010 10-Q 30 Jul 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.